Rafael Bejar, MD, PhD¹, Elli Papaemmanuil, PhD^2*, Torsten Haferlach³, Guillermo Garcia-Manero, MD⁴, Jaroslaw P. Maciejewski, MD, Ph.D.⁵, Mikkael A. Sekeres, MD, MS⁶, Matthew J. Walter, MD⁷, Timothy A. Graubert, MD⁸, Mario Cazzola, MD⁹, Luca Malcovati, MD^10*, Seishi Ogawa, MD, Ph.D.¹¹, Pierre Fenaux, MD, PhD¹², Eva Hellstrom-Lindberg, MD, PhD¹³, Wolfgang Kern, MD³, Jacqueline Boultwood, PhD¹⁴, Andrea Pellagatti, PhD^15*, David Bowen, MD, PhD¹⁶, Sudhir Tauro, PhD^17*, Michael J Groves, PhD^18*, Paresh Vyas, MD, PhD¹⁹, Lynn Quek, MD^20*, Aziz Nazha, MD²¹, Felicitas Thol, MD²², Michael Heuser, M.D.²³, Lee-Yung Shih, MD²⁴, Eric Padron, MD²⁵, David Sallman, M.D.²⁶, Rami S. Komrokji, MD²⁷, Alan F. List, MD²⁸, Valeria Santini, MD²⁹, Michaela Fontenay, MD, PhD^30*, Peter J Campbell, MD, PhD^31*, Heinz Tüchler^32*, Kristen Stevenson, MS^33*, Donna S Neuberg, ScD³³, Peter Greenberg, MD³⁴ and Benjamin L Ebert, MD, PhD³⁵

¹UCSD Moores Cancer Center, La Jolla, CA
²Memorial Sloan Kettering Cancer Center, New York
³MLL Munich Leukemia Laboratory, Munich, Germany
⁴Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
⁵Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁶Leukemia Program, Cleveland Clinic, Cleveland, OH
⁷Dept of Medicine, Div of Oncology, Washington Univ. in St. Louis, Saint Louis, MO
⁸Massachusetts General Hospital / Harvard Medical School, Boston, MA
⁹Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁰Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
¹¹Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
¹²Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
¹³Dept. of Med., Div. of Hem., Karolinska Institutet, Stockholm, Sweden
¹⁴LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, United Kingdom
¹⁵University of Oxford, Oxford, United Kingdom
¹⁶St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom
¹⁷Division of Cancer Research, Dundee School of Medicine, Dundee, United Kingdom
¹⁸Dept of Haematology, Ninewells Hospital, Dundee, United Kingdom
¹⁹MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine and Department of Haematology, University of Oxford and Oxford University Hospitals NHS Trust, UK, Oxford, United Kingdom
²⁰Haematology, London, United Kingdom
²¹Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
²²Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
²³Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
²⁴Department of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, College of Medicine Chang Gung University, Taipei, Taiwan
²⁵Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²⁶Dept. of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²⁷Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²⁸Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
²⁹AOU Careggi, University of Florence, Florence, Italy
³⁰Cochin Hospital, University Paris 5, Paris, France
³¹Cancer genome Project, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
³²Ludwig Boltzmann Institute for Leukemia Resaerch, Vienna, Austria
³³Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
³⁴Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
³⁵Division of Hematology, Brigham and Women's Hospital, Boston, MA

Mikkael A. Sekeres, MD, MS¹, Megan Othus, PhD^2*, Alan F. List, MD³, Olatoyosi Odenike, MD⁴, Richard M. Stone, MD⁵, Steven D. Gore, MD⁶, Mark R Litzow, MD⁷, Rena Buckstein, MD, FRCPC⁸, Min Fang, MD, PhD^9*, Diane Roulston, Ph.D.^10*, Clara D. Bloomfield, MD¹¹, Yanming Zhang, MD¹², Mario R. Velasco, MD^13*, Rakesh Gaur, MD, MPH¹⁴, Ehab Atallah, MD¹⁵, Eyal C. Attar, MD¹⁶, Frederick R Appelbaum, MD¹⁷ and Harry P. Erba, MD, PhD^18*

¹Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
²SWOG Statistical Center, Seattle, WA
³Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
⁴University of Chicago Medical Center, Chicago, IL
⁵Hematologic Oncology, Dana Farber Cancer Institute, Boston, MA
⁶Yale Cancer Center, New Haven, CT
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Center, Toronto, Canada
⁹Seattle Cancer Care Alliance, Seattle, WA
¹⁰Pathology, Cytogenetics Laboratory, University of Michigan, Ann Arbor, MI
¹¹Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹²Department of Pathology, Northwestern University, Chicago, IL
¹³Cancer Care Specialists of Central Illinois, Heartland NCORP, Decatur, IL
¹⁴Kansas City NCORP, Prairie Village, KS
¹⁵Department of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
¹⁶Massachusetts General Hospital, Harvard Medical School, Boston, MA
¹⁷Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁸University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL

Rami S. Komrokji, MD¹, Amy E. DeZern, MD, MHS², Katrina Zell, MA, MS^3*, Najla H. Al Ali, BDS, MSc^1*, Christopher Estling^3*, Cassie Zimmerman, MPH^3*, Wesley Hand^2*, Francis Brown^4*, Nicole Rizzo^5*, John Barnard, PhD^3*, Gail J Roboz, MD⁶, Guillermo Garcia-Manero, MD⁷, David P. Steensma, MD⁴ and Mikkael A. Sekeres, MD, MS³

¹Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
³Leukemia Program, Cleveland Clinic, Cleveland, OH
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY
⁶Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY
⁷Department of Leukemia, MD Anderson Cancer Center, Houston, TX

Shyamala C. Navada, MD¹, Lewis R. Silverman, MD^1*, Katherine P. Hearn, BSN, RN^2*, Rosalie Odchimar-Reissig, RN^1*, Erin P. Demakos, RN, CCRN^1*, Yesid Alvarado, MD², Naval Daver, MD³, Courtney DiNardo, MD², Marina Konopleva, MD, PhD², Gautam Borthakur, MD², Naveen Pemmaraju, MD², Tapan Kadia, MD³, Pierre Fenaux, MD, PhD⁴, Steve Fruchtman, MD^5*, Nozar Azarnia, PhD^5* and Guillermo Garcia-Manero, MD²

¹Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Service d’Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
⁵Onconova Therapeutics, Inc, Newtown, PA

Guillermo Garcia-Manero, MD¹, Jesus G. Berdeja, MD², Rami S. Komrokji, MD³, James Essell, MD⁴, Roger M. Lyons, MD⁵, Michael Maris, MD⁶, Amy E. DeZern, MD, MHS⁷, Mikkael A. Sekeres, MD, MS⁸ and Gail J Roboz, MD⁹

¹Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
²Sarah Cannon Research Institute, Nashville, TN
³H. Lee Moffitt Cancer Center, Tampa, FL
⁴Oncology/Hematology Care, Cincinnati, OH
⁵Cancer Care Center of South Texas, San Antonio, TX
⁶Colorado Blood Cancer Institute, Denver, CO
⁷Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁸Leukemia Program, Cleveland Clinic, Cleveland, OH
⁹Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY

Michael Heuser, MD¹, Christian Koenecke, M.D.^2*, Razif Gabdoulline^3*, Patrick Löffeld^4*, Vera Dobbernack^4*, Victoria Panagiota, M.D.^2*, Sabrina Klesse^1*, Michael Stadler, MD^1*, Juergen Krauter, MD^5*, Elke Dammann^4*, Martin Wichmann^6*, Rabia Shahswar, M.D.^2*, Sabin Bhuju^7*, Robert Geffers, PhD^8*, Brigitte Schlegelberger, MD, PhD⁹, Gudrun Göhring, MD^9*, Moritz Kleine^4*, Wiebke Brauns^4*, Uwe Platzbecker, MD¹⁰, Christian Thiede, MD¹¹, Thomas Schroeder, MD^12*, Guido Kobbe, MD^13*, Arnold Ganser, M.D.¹, Nicolaus Kroeger, MD¹⁴ and Felicitas Thol, MD¹

¹Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
²Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
³Dept. of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁴Hannover Medical School, Hannover, Germany
⁵Department of Hematology and Oncology, Klinikum Braunschweig, Braunschweig, Germany
⁶Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannoverg, Germany
⁷Helmholtz Centre for Infection Research, Braunschweig, Germany
⁸Genome Analysis Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany
⁹Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
¹⁰Carl Gustav Carus an der Technischen Universität, Universitätsklinikum, Dresden, Germany
¹¹Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany
¹²Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
¹³Dept. of Hematology, Oncology and clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany
¹⁴Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany